Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study - Quartier, P; Alexeeva, E; Constantin, T (Arthritis Rheumatol, 2021)
et al.